Cargando…
An evaluation into the use of procalcitonin levels as a biomarker of bacterial sepsis to aid the management of intrapartum pyrexia and chorioamnionitis
BACKGROUND: Procalcitonin is an established biomarker for bacterial sepsis in the nonpregnant population with better diagnostic and prognostic value for bacterial infections. OBJECTIVE: This study aimed to evaluate whether procalcitonin levels could be used in the diagnosis and management of intrapa...
Autores principales: | Walker, Sarah, Harding, Irasha, Soomro, Kamran, Bamber, Andrew R., Carrick, Sophie, Waheed, Abdul H., Liebling, Rachel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563784/ https://www.ncbi.nlm.nih.gov/pubmed/36276783 http://dx.doi.org/10.1016/j.xagr.2022.100064 |
Ejemplares similares
-
The dynamics of procalcitonin in COVID-19 patients admitted to Intensive care unit - a multi-centre cohort study in the South West of England, UK.
por: Williams, Philip, et al.
Publicado: (2021) -
Suspected clinical chorioamnionitis with peak intrapartum temperature <38(0)C: the prevalence of confirmed chorioamnionitis and short term neonatal outcome
por: Vellamgot, Anvar Paraparambil, et al.
Publicado: (2022) -
Maternal serum procalcitonin levels in prediction of chorioamnionitis in women with preterm premature rupture of membranes
por: Bakar, Rabia Zehra, et al.
Publicado: (2019) -
Chorioamnionitis and Neonatal Sepsis from Community-associated MRSA
por: Pimentel, Jason D., et al.
Publicado: (2009) -
Procalcitonin as a marker of bacterial sepsis in immunocompromised patients
por: Gatserelia, Lana, et al.
Publicado: (2012)